Infusion of haploidentical NKG2D-CAR-TCD45RA- cells in two pediatric patients with advanced relapsed and refractory acute leukemia was safe but achieved no clinical benefits

Leuk Lymphoma. 2022 Aug;63(8):1970-1974. doi: 10.1080/10428194.2022.2057490. Epub 2022 Apr 3.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD19
  • Child
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Immunotherapy, Adoptive / adverse effects
  • Leukemia* / therapy
  • NK Cell Lectin-Like Receptor Subfamily K
  • Receptors, Chimeric Antigen*

Substances

  • Antigens, CD19
  • NK Cell Lectin-Like Receptor Subfamily K
  • Receptors, Chimeric Antigen